IGM Biosciences, Inc. Operating Lease, Liability, Current
IGM Biosciences, Inc. had Operating Lease, Liability, Current of $0 as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-07-31
- 2025-06-30: Operating Lease, Liability, Current $0.00.
- 2025-03-31: Operating Lease, Liability, Current $7.02M.
- 2024-12-31: Operating Lease, Liability, Current $7.12M.
- 2024-09-30: Operating Lease, Liability, Current $6.70M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 |
| 2025-03-31 | $7.02M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $7.12M 10-Q · filed 2025-07-31 |
| 2024-09-30 | $6.70M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $5.94M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $6.63M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $5.83M 10-K · filed 2025-03-06 |
| 2023-09-30 | $6.21M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $6.88M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $6.43M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $5.82M 10-K · filed 2024-03-07 |
| 2022-09-30 | $4.35M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $4.27M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $4.05M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $3.32M 10-K · filed 2023-03-30 |
| 2021-09-30 | $3.18M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $3.50M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $3.33M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.67M 10-K · filed 2022-03-29 |
| 2020-09-30 | $2.62M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.58M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.53M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $2.48M 10-K · filed 2021-03-30 |
| 2019-09-30 | $1.56M 10-Q · filed 2019-11-07 |
| 2019-01-01 | $708.00K 10-K · filed 2020-03-26 |